Natco Pharma, after receiving final approval from the US health regulator in August this year, launched a generic Tamiflu capsules that are used in the treatment of influenza, in the American market.

The company has announced in a BSE filing the “launch of the first generic equivalent of Tamiflu oral capsules….through its marketing partner Alvogen.”

The capsules are generic versions of Roche’s Tamiflu drug and are in the strengths of 30 mg, 45 mg and 75 mg.

Read EquityPandit’s Nifty Pharma Outlook for this week